Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia 3Hematologic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Mycosis Fungoides 1Lymphoma, T-Cell 1Lymphoma 1Leukemia-Lymphoma, Adult T-Cell 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 160Peripheral Blood Stem Cell Transplantation 85fludarabine phosphate 81Filgrastim 78Methotrexate 69Etoposide 68Cytarabine 62Rituximab 61Radiotherapy 56Cyclosporine 52Mycophenolic Acid 51Vincristine 50Whole-Body Irradiation 48Busulfan 46Tacrolimus 41Antilymphocyte Serum 40Melphalan 39Dexamethasone 39Prednisone 36Methylprednisolone 35Doxorubicin 35fludarabine 28Granulocyte Colony-Stimulating Factor 25Calcium Dobesilate 25merphos 24Leucovorin 23Cord Blood Stem Cell Transplantation 22sargramostim 18dexamethasone acetate 18dexamethasone 21-phosphate 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Burkitt Lymphoma × Introns × Other hematologic neoplasm × Clear all
NCT00002621 2014-07-24

Interferon Alfa in Treating Children With HIV-Related Cancer

Children's Oncology Group

Phase 2 Completed
8 enrolled
LymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Leukemia, Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡